Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. - Wikidata - awgldk - TriplyDB

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

http://www.wikidata.org/entity/Q34316470

about

Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.Investigation of anti-infection mechanism of lactoferricin and splunc-1.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Treatment of acute lymphoblastic leukemia from traditional chinese medicine Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine.In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation.In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine.Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.Multitargeted bioactive ligands for PPARs discovered in the last decade.Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine.

P2860

Q30366183-6FC9E696-4514-4474-8E32-252182734701 Q30422493-625BEEDE-4666-4B52-8296-A6A1D99854BE Q30657668-3E7AF0B0-70D5-4EA9-B739-1CBE450C0E9A Q33608964-49D73114-0E61-49C6-B347-0C4F1FA3C535 Q33614360-779B483F-92BF-4F29-B236-F79986DAAE12 Q33614602-E5CF7D9B-0556-4B93-97C8-90325601AA8B Q33614632-77455CA3-741A-4AB2-9D67-089738EF7567 Q33661003-58682532-56FB-4936-8AD1-16D10D54AE62 Q33666808-33A91213-608F-49E0-9F39-9D131F63787B Q33668052-E502660D-25FF-465D-AFA4-18EA4690FF31 Q33668408-C90CFDE4-E7BE-4FF9-BA79-DFC289B93BC1 Q33736326-32645BCC-3242-49D8-B978-A3169DE04BE1 Q33746550-673B9038-6DA1-4517-947F-5DF0FFD96266 Q33747644-E55AAE47-BC9D-4B56-946B-AC47D522CCCA Q33757779-5DEDE345-C21B-4853-B147-2FA056749A3A Q33790946-66452CC0-8D22-4B39-8956-D0DD3BCC8507 Q33821712-460722F2-60D4-4695-9BF3-02833797533E Q33876312-197BA61D-9878-45DF-AECF-A87F89BC0489 Q33876519-CB44F59D-7420-4C8E-B56A-7C6C6BC960B5 Q33876600-1A03AA42-1974-45B5-AB25-C42CD4D3F3C0 Q33893880-01426E2B-9B9E-498E-BEBE-94CDB5425B7B Q33895166-56343BF0-979D-459A-9211-AFD6809E63CA Q34022289-AD48ADF7-35D0-4842-9193-F5C61727BDE5 Q35137889-B0591CB6-33F1-4B33-A31F-973BB70A7F77 Q37556518-BC460A54-68E6-44C2-9F70-5F0A8E7A3AFF Q38273378-BD505F3F-604F-4155-95B9-1225EFC5D504 Q38869029-5348C76A-C1B3-48BF-B01B-F14484C2BCAC Q44806080-2C06EE12-A1EC-490F-908D-4F5F133264DF Q47724399-91897D09-B216-4EEC-9E07-6E46FBE84C06

P2860

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

http://www.wikidata.org/entity/Q34316470

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@ast

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@en

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@nl

type

label

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@ast

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@en

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@nl

prefLabel

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@ast

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@en

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

@nl

P1433

Q34316470-1A10D7C0-FD06-457B-AC47-9EF7A0DE3D1D

P1476

Q34316470-2A2D6FA7-CCAD-4680-ACC1-E74170B70630

P2093

Q34316470-321C211D-17C9-46C5-BB51-3E0A64C1A002

Q34316470-577273D4-0A0D-4A3C-A721-D97B12A7E7F0

Q34316470-8A138971-3C1D-4127-8774-7985BE59938C

Q34316470-AB683175-7008-4C38-B630-FF9305A68760

P2860

Q34316470-0012AFA7-FC5F-4FC6-A82E-DC0DC2D41B9F

Q34316470-065B7B9A-E7C9-46E4-BBA1-4411405F8012

Q34316470-0CC37F36-1015-47AF-8C7F-B8EF36695185

Q34316470-18B187C1-72DF-4E34-9219-40384EE5229A

Q34316470-1D03BC92-802D-4A42-9B9E-6CB44F229780

Q34316470-1D0D86A0-97B8-48C4-A3F1-FBEAC6776CFE

Q34316470-1F225FD2-4621-4A5D-8CDD-B66D66DC95D7

Q34316470-207229B0-0633-4164-BFCD-D8D6C8A3B1DF

Q34316470-2154956F-D557-4B74-83C3-AC7783D1651E

Q34316470-324A734A-EBCC-4EC8-943A-3971B00BA6BE

P304

Q34316470-88052825-3D68-449E-AECB-555C67D8A5FB

P31

Q34316470-C1A9A8A6-BF66-448C-B945-C2A460E2217A

P356

Q34316470-C5C0E2FA-A39F-40FE-8B15-1DC8AEC2A982

P433

Q34316470-9965086C-D0AD-444B-A409-D7D1CC018A01

P478

Q34316470-DFAAE93C-A7B4-4AEC-9D1D-BBC7007EF492

P50

Q34316470-35397BDF-4BD4-4E5E-BC3C-FDD2162B11B0

Q34316470-94EA2AF1-6354-459D-8E88-93D7824755FD

P577

Q34316470-045FB18D-3994-4643-A1D1-B734E08DDFB4

P698

Q34316470-2842D5BD-7EFB-4555-92C0-AA40EC69224C

P356

07391102.2012.689699

P1433

Journal of Biomolecular Structure and Dynamics

P1476

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine

@en

P2093

Calvin Yu-Chian Chen

http://www.w3.org/2001/XMLSchema#string

Hung-Jin Huang

http://www.w3.org/2001/XMLSchema#string

Kuan-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Su-Sen Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)

T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives

Structure validation by Calpha geometry: phi,psi and Cbeta deviation

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

P304

662-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07391102.2012.689699

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22731403

http://www.w3.org/2001/XMLSchema#string